Skip to search formSkip to main contentSkip to account menu

Hemofil

Known as: Hemofil HM, Hemofil M, Hemophil 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Summary.  In order to describe the haemostatic role of a variation in inhibitor reactivity with different factor VIII (FVIII… 
2005
2005
In the United States, at least 70% of patients with severe hemophilia A who were treated prior to 1984 with concentrates are HIV… 
1992
1992
Summary A recombinant FVIII preparation, Recombinate™, was compared with a high-purity plasma-derived concentrate, Hemofil® M, in… 
Review
1991
Review
1991
ConclusionsThe Method M process was developed to reduce the risk of virus transmission associated with the therapeutic use of AHF… 
1991
1991
Summary In response to reports of discrepant in vitro assays of high-purity concentrates, a double-blind crossover study of in… 
Highly Cited
1985
Highly Cited
1985
An acquired inhibitor of von Willebrand factor (vWF) activity occurring in a patient with benign gammopathy and von Willebrand… 
1972
1972
Two factor VIII concentrates, Courtland and Hemofil, were evaluated during 64 courses of therapy in 26 classic hemophiliacs who…